Yubo International Biotech Ltd (YBGJ)
0.80
-0.10
(-11.10%)
USD |
OTCM |
May 17, 12:57
Yubo International Biotech Gross Profit Margin (Quarterly): 81.05% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 81.05% |
| September 30, 2023 | 80.30% |
| June 30, 2023 | 61.89% |
| March 31, 2023 | 36.84% |
| December 31, 2022 | 43.50% |
| September 30, 2022 | 65.84% |
| June 30, 2022 | 73.41% |
| March 31, 2022 | 54.34% |
| Date | Value |
|---|---|
| December 31, 2021 | 65.87% |
| September 30, 2021 | 74.46% |
| June 30, 2021 | 60.60% |
| March 31, 2021 | 68.26% |
| December 31, 2020 | 91.55% |
| September 30, 2020 | 67.61% |
| June 30, 2020 | 91.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
36.84%
Minimum
Mar 2023
91.59%
Maximum
Jun 2020
67.81%
Average
67.61%
Median
Sep 2020
Gross Profit Margin (Quarterly) Benchmarks
| Meihua International Medical Technologies Co Ltd | -- |
| Hologic Inc | 53.28% |
| Nuwellis Inc | 64.14% |
| Varex Imaging Corp | 31.91% |
| Quanterix Corp | 60.87% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -59.79% |
| Profit Margin (Quarterly) | -2.32K% |
| Operating Margin (Quarterly) | -2.32K% |
| Return on Net Operating Assets | -63.62% |